Related Experiment Video
Updated: Jul 6, 2026

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
Published on: September 28, 2022
Guidelines for heart transplantation
N de Jonge1, J H Kirkels, C Klöpping
1University Medical Center Utrecht, Utrecht, the Netherlands.
Insights
Updated guidelines define heart transplantation indications for end-stage heart failure. Key contraindications include irreversible pulmonary hypertension, active infections, and malignancy, ensuring patient suitability for this advanced treatment.
Area of Science:
- Cardiology
- Cardiothoracic Surgery
- Transplantation Medicine
Background:
- Heart failure treatment and prognosis have evolved significantly.
- Existing heart transplantation criteria require updates to reflect current medical advancements.
- Guidelines are essential for standardizing patient selection for heart transplantation.
Purpose of the Study:
- To provide updated guidelines for heart transplantation indications and contraindications.
- To define criteria for end-stage heart disease eligible for transplantation.
- To outline contraindications that preclude patients from receiving a heart transplant.
Main Methods:
- Development of guidelines by a committee under the Netherlands Society of Cardiology and Netherlands Association for Cardiothoracic Surgery.
- Review of current understanding of heart failure management and transplantation outcomes.
- Establishment of clear criteria for patient selection, including indications and contraindications.
Main Results:
- Heart transplantation is indicated for end-stage heart disease unresponsive to conservative measures.
- Contraindications include irreversible pulmonary hypertension, active infections, malignancy, non-compliance, severe vascular disease, and organ dysfunction.
- Final acceptance relies on transplant team expertise in advanced heart failure and transplantation.
Conclusions:
- Updated guidelines offer a framework for heart transplantation candidacy.
- Broadly defined criteria acknowledge the complexities of end-stage heart failure and evolving therapies.
- Transplant team evaluation is crucial for optimal patient selection.
Abstract:
Based on the changes in the field of heart transplantation and the treatment and prognosis of patients with heart failure, these updated guidelines were composed by a committee under the supervision of both the Netherlands Society of Cardiology and the Netherlands Association for Cardiothoracic surgery (NVVC and NVT).THE INDICATION FOR HEART TRANSPLANTATION IS DEFINED AS: 'End-stage heart disease not remediable by more conservative measures'.CONTRAINDICATIONS ARE: irreversible pulmonary hypertension/elevated pulmonary vascular resistance; active systemic infection; active malignancy or history of malignancy with probability of recurrence; inability to comply with complex medical regimen; severe peripheral or cerebrovascular disease and irreversible dysfunction of another organ, including diseases that may limit prognosis after heart transplantation.Considering the difficulties in defining end-stage heart failure, estimating prognosis in the individual patient and the continuing evolution of available therapies, the present criteria are broadly defined. The final acceptance is done by the transplant team which has extensive knowledge of the treatment of patients with advanced heart failure on the one hand and thorough experience with heart transplantation and mechanical circulatory support on the other hand. (Neth Heart J 2008;16:79-87.).
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure

